Ance. Received: 9 October 2015 Accepted: 5 NovemberAdditional filesAdd…

Ance. Received: 9 October 2015 Accepted: 5 NovemberAdditional filesAdditional file 1: Table S1. Efficacy of IVIg as induction therapy on gluten ataxia. Summary of four studies. (DOC 35 kb) Additional file 2: Table S2. Effect of immunotherapy on cerebellar ataxia with paraneoplastic cerebellar degeneration. Summary of 9 studies. (DOC 39 kb)References 1. Mitoma H, Adhikari K, Aeschlimann D, Chattopadhyay P, Hadjivassiliou M, Hampe CS, et al. Consensus Paper: Neuroimmune mechanisms of cerebellar ataxias. Cerebellum. 2015. doi:10.1007/s12311-015-0664-x. 2. Giommeto B, Grisold W, Vitaliani R, Graus F, Honnorat J, Bertolini G, et al. Paraneoplastic neurologic syndromes in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol. 2010;67:330?. 3. Brouwer B. Beitrag zur kenntnis der chronischen diffusen kleinhirnerkrankungen. Neurol Zentralbl. 1919;38:674?2. 4. Ducray F, Demarquay G, Graus F, Decullier E, Antoine J-C, Giometto B, et al. Seronegative paraneoplastic cerebellar degeneration: the PNS Euronetwork experience. Eur J Neurol. 2014;21:731?. 5. Hadjivassiliou M, Gr ewald RA, Chattopadhyay AK, Davies-Jones GA, Gibson A, Jarratt JA, et al. Clinical, radiological, neurophysiological and neuropathological characteristics of gluten ataxia. Lancet. 1998;352:1582?. 6. Shaw PJ, Walls TJ, Newman PK, Cleland PG, Cartlidge NE. Hashimoto's encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers-report of 5 cases. Neurology. 1991;41:228?3. 7. Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, Andres C, et al. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies. Study of 14 patients. Arch Neurol. 2001;58:225?0. 8. Jarius S, Wildemann B. `Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: AntimGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII. J Neuroinflammation. 2015. doi:10.1186/s12974-015-0356-y. 9. Jarius S, Wildemann B. `Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKCgamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC. J Neuroinflammation. 2015. doi:10.1186/s12974-015-0357-x. 10. Jarius S, Wildemann B. `Medusa-head ataxia': the expanding spectrum of Purkinje PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/10389946 cell antibodies in Nelfinavir (Mesylate) autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook. J Neuroinflammation. 2015. doi:10.1186/s12974-015-0358-9. 11. Hadjivassiliou M, Boscolo S, Tongiorgi E, Grunewald RA, Sharrack B, Sanders DS, et al. Cerebellar ataxia as a possible organ specific autoimmune disease. Movement Disord. 2008;23:1270?77. 12. Hadjivassiliou M, Davies-Jones GAB, Sandres DS, Gr ewald RA. Dietary treatment of gluten ataxia. J Neurol Neurosurg Psychiatry. 2003;74:1221?.Mitoma et al. Cerebellum Ataxias (2015) 2:Page 9 of13. B k K, Melms A, Schulz JB, Dichgans J. Effective of intravenous immunoglobin therapy in cerebellar ataxia associated with gluten sensitivity. Ann Neurol. 2001;50:827?. 14. Souayah N, Chin RL, Brannagan TH, Latov N, Green PHR, Kokoszka A, et al. Effect of intravenous immunoglobulin on cerebellar ataxia and neuropathic pain associated with celiac disease. Eur J Neurol. 2008;15:1300?. 15. Hadjivassiliou M, Gr ewald RA, Davies-Jones GAB. Gluten sensitivity as a neurological illness. J Neurol Neurosurg Psychiatry. 2002;72:560?. 16. Hadjivassiliou M, Sanders DS, Woodroofe N,.